Technical, Economic and Legal Obstacles to the Development of Vaccines and Other Therapeutics for Potential Bioterrorism Agents
Princeton University Program on Science and Global Security Biosecurity Seminar Series
Sponsored by the Carnegie Corporation.
Speaker: Adel Mahmoud, President, Merck Vaccines, Merck and Company, Inc.
Date: March 26, 2004
- March 26, 2004
- | Filed under North America and Bioterrorism